artesunate IV
Selected indexed studies
- IV artesunate for severe malaria. (Med Lett Drugs Ther, 2020) [PMID:32960866]
- Discovery of Platinum(IV)-Artesunate Multiaction Prodrugs as Potent Antitumor and Antimalarial Agents. (J Med Chem, 2023) [PMID:37306362]
- Combination astragaloside IV and artesunate preserves blood-brain barrier integrity by modulating astrocytes and tight junction proteins in Plasmodium yoelii infection. (Int J Parasitol Drugs Drug Resist, 2025) [PMID:40466596]
_Worker-drafted node — pending editorial review._
Connections
artesunate IV is a side effect of
Sources
- IV artesunate for severe malaria. (2020) pubmed
- Discovery of Platinum(IV)-Artesunate Multiaction Prodrugs as Potent Antitumor and Antimalarial Agents. (2023) pubmed
- Combination astragaloside IV and artesunate preserves blood-brain barrier integrity by modulating astrocytes and tight junction proteins in Plasmodium yoelii infection. (2025) pubmed
- Delayed haemolysis after IV artesunate therapy for P. falciparum infection. (2022) pubmed
- UK malaria treatment guidelines 2016. (2016) pubmed
- Malaria: An Update. (2017) pubmed
- A platinum(IV)-artesunate complex triggers ferroptosis by boosting cytoplasmic and mitochondrial lipid peroxidation to enhance tumor immunotherapy. (2024) pubmed
- IV artesunate for severe malaria. (2008) pubmed
- Artesunate modulates expression of matrix metalloproteinases and their inhibitors as well as collagen-IV to attenuate pulmonary fibrosis in rats. (2016) pubmed
- Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria. (2019) pubmed